Commerce: Clinical Trials

23 trials of Commerce, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 2 recruiting. 16 Not applicable, 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 15, Recruiting 1
Phase 25Completed 4, Recruiting 1
Phase 12Completed 2

Follow Commerce: new trials by email Literature Review of Commerce trials Research Report on Commerce

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mini-RISK in Agder: A Cluster Randomized Controlled Trial of a Low-Threshold School-Based Program for Anxious Students Delivered by School Personnel in the School Setting
Mini-RISK School-based group CBT, Usual School Nurse Support - Anxiety
Not applicableRecruitingSorlandet Hospital HF6402026-11-202026-11-18
Project CARE-D - Online Caregiver Education for Dementia
Structured Retrieval Practice, Business as usual learning, Standard Retrieval Practice - Dementia
Phase 1CompletedTexas Christian University652025-05-012026-02-04
Testing Legally Feasible Options Studies 2/3
Many posters with prices, Many posters, no prices, Fewer posters, no price restrictions - Tobacco Use
Not applicableCompletedRAND4452022-10-122025-01-13
Effects of Narratives on Demand for Low and High Ventilated Cigarettes and Substitution for Alternative Products
High-ventilated cigarette alone, Low-ventilated cigarette alone, High- and low-ventilated cigarette with high-ventilated cigarettes increasing in price - Cigarette Smoking
Not applicableCompletedVirginia Polytechnic Institute and State University892022-08-082025-07-02
PRICE vs PEACE and LOVE in Adolescent Lateral Ankle Sprain Rehabilitation
PRICE + NSAIDs protocol, PEACE and LOVE protocol - Lateral Ankle Sprain, Ankle Injuries
Not applicableCompletedLithuanian University of Health Sciences762022-02-022025-12-23
Impact Evaluation of Triggerise's Tiko Platform
Tiko Platform Behavioural cum mHealth Intervention, Standard of Care / Business as Usual - Contraception, Iron Deficiency Anemia of Pregnancy
Not applicableCompletedNetwork for Engineering and Economics Research and Management17082021-02-152023-02-13
SNIFF Multi-Device Study 2
20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company), 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company) - Mild Cognitive Impairment, Cognitive Impairment
Phase 2CompletedWake Forest University Health Sciences132020-07-162026-10-07
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
gemcitabine and oxaliplatin., Afatinib - Gallbladder Carcinoma
Phase 2RecruitingShanghai Jiao Tong University School of Medicine1022020-06-012024-10-16
Occupational Heat Stress on Workers' Productivity
Work/ rest scenario, Hydration scenario, Clothing scenario - Risk of Heat Stress
Not applicableCompletedPetros Dinas2482019-07-052023-11-29
Building Sentences With Preschoolers Who Use AAC
AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder
Phase 2CompletedUniversity of Central Florida702018-05-112024-01-08
Improving Response to Intervention in Students With or at Risk of Reading Disabilities
Reading, Mindset, Reading Embedded with Mindset - Reading Problem
Not applicableCompletedVanderbilt University5802017-08-182021-08-04
Evaluation of the Making Proud Choices! Teen Pregnancy Prevention Program
Making Proud Choices, Business as usual - Teen Pregnancy Prevention
Not applicableCompletedMathematica Policy Research, Inc.28102017-01-012021-04-29
Efficacy of the START-Play Program for Infants With Neuromotor Disorders
START-Play intervention, Business as usual - Cerebral Palsy, Developmental Delay
Not applicableCompletedDuquesne University1342016-01-012024-03-18
Using NIATx Strategies to Implement Integrated Services in Routine Care
Coach Site Visit, Walk-through, Learning Sessions - Addiction, Mental Health Disorder
Not applicableCompletedUniversity of Wisconsin, Madison492015-09-302022-03-31
Study of the Collaborative Life Skills Program
Collaborative Life Skills Intervention (CLS), Business As Usual - Attention Deficit Hyperactivity Disorder Symptoms
Not applicableCompletedUniversity of California, San Francisco5042012-09-012019-06-18
An Evaluation of Pono Choices: A Culturally Responsive Teen Pregnancy and STI Prevention Program
Pono Choices, Business as Usual - Teen Pregnancy, Sexually Transmitted Infections
Not applicableCompletedUniversity of Hawaii17832012-01-012020-11-04
Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia
CBT, D-Cycloserine - Agoraphobia
Phase 2CompletedCharite University, Berlin, Germany732011-11-012014-05-19
Brief Intervention for Medication Overuse Headache
Brief intervention, Business as usual, Screening and outcome evaluation only - Medication-overuse Headache, Chronic Headache
Not applicableCompletedUniversity Hospital, Akershus1232011-03-012015-12-30
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
exenatide injection, Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R, Pioglitazone - Diabetes Mellitus, Type 2, Newly Diagnosed
Not applicableCompletedSun Yat-sen University4162010-08-012013-08-21
Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
Fluticasone propionate, Budesonide, Montelukast - Asthma
CompletedGlaxoSmithKline99062009-06-012017-07-06

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Agoraphobia (1)  ·  Ankle Injuries (1)  ·  Anxiety Disorders (1)  ·  Asthma (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Behavior, Addictive (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Palsy (1)  ·  Cigarette Smoking (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Down Syndrome (1)  ·  Gallbladder Neoplasms (1)  ·  Headache Disorders (1)

Sponsors

Acrotech Biopharma Inc. (1)  ·  Charite University, Berlin, Germany (1)  ·  Duquesne University (1)  ·  GlaxoSmithKline (1)  ·  Karolinska Institutet (1)  ·  Lithuanian University of Health Sciences (1)  ·  Mathematica Policy Research, Inc. (1)  ·  Network for Engineering and Economics Research and Management (1)  ·  Petros Dinas (1)  ·  RAND (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Sorlandet Hospital HF (1)  ·  Sun Yat-sen University (1)  ·  Texas Christian University (1)  ·  University Hospital, Akershus (1)

Countries

United States (10)  ·  China (2)  ·  Norway (2)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Lithuania (1)  ·  Sweden (1)

Top investigators

Andreas Flouris (1)  ·  Christofer Lundqvist, MD, PhD (1)  ·  Emilis Cekanauskas, Professor (1)  ·  Jianping Weng, Doctor (1)  ·  Kelly D Roberts, PhD (1)  ·  Linda Pfiffner, PhD (1)  ·  Maria C Bodin, PhD (1)  ·  Matas Meskauskas (1)  ·  Michael Saunders, MD (1)  ·  Michele A. Lobo, PhD (1)  ·  Regina T Harbourne, PhD (1)  ·  Sarah W McCoy, PhD (1)  ·  Simone French (1)

Results publications

PMID 21676046, PMID 22883540, PMID 25112307, PMID 26563095, PMID 26645391, PMID 27566117, PMID 27689477, PMID 28369734, PMID 29588050, PMID 30724760, PMID 30740698, PMID 31012090, PMID 31651302, PMID 33382406, PMID 34346729, PMID 34988462, PMID 35350970, PMID 36854604, PMID 37790170, PMID 38099897, PMID 38262982, PMID 38359542, PMID 39965897, PMID 40537937

NIH funding

P01CA217806 (1), R01CA236608 (1), R01DA037222 (1), R01DC016321 (1), R01HL079478 (1)